Why Experimental Design in Biotech is Broken and How to Fix It

On this episode of Data in Biotech, we’re excited to be joined by Markus Gershater, Chief Scientific Officer and CoFounder of Synthace - a digital experiment platform built for high-performance life science R&D teams to help them run more powerful experiments and accelerate scientific progress.

On this episode of Data in Biotech, we’re excited to be joined by Markus Gershater, Chief Scientific Officer and CoFounder of Synthace - a digital experiment platform built for high-performance life science R&D teams to help them run more powerful experiments and accelerate scientific progress.

Our own Ross Katz speaks with Markus on what’s broken about:

  • What’s broken about how laboratories across the globe run biological experiments at scale

  • The opportunity that exists for researchers in striving to achieve experimental design automation processes

  • Why, as an industry, we must move towards implementing infrastructure that enables multifactorial experiments versus one-factor experiments

  • And the role of AI in making sense of complex systems.

Listen here:

If you’re a biotech company struggling to transform your business with data, CorrDyn can help.

Whether you need to supplement existing technology teams with specialist expertise or launch a data program that lays the groundwork for future internal hires, you can partner with Corrdyn to unlock the potential of your business data - today.

Visit connect.corrdyn.com/biotech to learn more.

Join newsletter
Stay up to date with new case studies. We promise no spam, just good content.

More blog posts

see all